Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,104,560 | 6,660,480 | 4,413,290 | 3,561,040 | 2,695,510 |
| Marketable Securities | 1,370,320 | 1,849,810 | 2,913,170 | 3,702,220 | 1,191,780 |
| Receivables | 4,332,430 | 4,426,640 | 4,236,300 | 3,859,420 | 3,672,860 |
| Inventories | 2,622,230 | 2,543,290 | 2,518,980 | 2,409,190 | 2,398,990 |
| Other current assets | 577,760 | 445,140 | 3,761,230 | 3,768,920 | 4,001,970 |
| TOTAL | $15,007,300 | $15,925,360 | $17,842,970 | $17,300,790 | $13,961,110 |
| Non-Current Assets | |||||
| Investments And Advances | 2,371,860 | 2,348,900 | 1,741,970 | 1,817,880 | 1,932,250 |
| Other Non-Current Assets | 20,887,100 | 21,994,640 | 19,599,970 | 18,757,980 | 18,687,430 |
| TOTAL | $23,258,960 | $24,343,540 | $21,341,940 | $20,575,860 | $20,619,680 |
| Total Assets | $43,485,810 | $45,691,440 | $44,257,860 | $42,957,480 | $39,730,480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,554,040 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,516,380 | 1,849,000 | 1,229,270 | 1,089,650 | 1,074,580 |
| Accrued Expenses | N/A | 0 | 534,260 | 459,780 | 491,010 |
| Other current liabilities | 3,663,340 | 4,101,190 | 3,818,360 | 3,453,760 | 3,650,550 |
| TOTAL | $7,258,250 | $8,027,540 | $5,810,840 | $5,524,550 | $5,490,560 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,885,070 | 7,045,800 | 7,900,800 | 7,979,850 | 5,455,240 |
| Other Non-Current Liabilities | 2,621,930 | 2,405,800 | 2,614,280 | 2,511,970 | 2,456,370 |
| TOTAL | $12,178,360 | $12,257,550 | $13,914,580 | $13,726,500 | $11,247,130 |
| Total Liabilities | $19,436,630 | $20,285,090 | $19,725,420 | $19,251,080 | $16,737,690 |
| Shareholders' Equity | |||||
| Common Shares | 622,900 | 635,620 | 635,620 | 641,970 | 641,760 |
| Retained earnings | 18,163,720 | 19,013,070 | 22,120,060 | 22,590,800 | 22,231,420 |
| Other shareholders' equity | 4,922,300 | 5,365,000 | 1,400,950 | 85,420 | -265,650 |
| TOTAL | $24,049,180 | $25,406,350 | $24,532,430 | $23,706,390 | $22,992,790 |
| Total Liabilities And Equity | $43,485,810 | $45,691,440 | $44,257,850 | $42,957,470 | $39,730,480 |